Wave Banks $170m Upfront In GSK Oligonucleotide Deal, Analysts Back Shift To Partnership Model

Lucrative Potential Milestones

 
• By Ayisha Sharma
  
Woman holding up vial containing RNA strand
Wave's PRISM Platform Can Edit, Splice And Silence RNA • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip